Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01494077 · ClinicalTrials.gov registry record
Accuracy of Dilution of EUS-FNA Pancreatic Cyst Fluid for Carcinoembryonic Antigen (CEA) Measurement
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 32
- Enrollment target
NCT01494077: Completed study, sponsored by University of California, Irvine.
NCT01494077 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01494077 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The purpose of this research project is to determine if pancreatic cyst fluid can be diluted and provide an accurate Carcinoembryonic Antigen (CEA) level. The investigators hypothesis is that pancreatic cyst fluid obtained by EUS-FNA can be diluted effectively and accurately for the measurement of CEA levels.
Primary Outcome
The primary aim of this study is to determine if pancreatic cyst fluid can be diluted and provide an accurate CEA level.
Interventions
- OTHER Laboratory processing for results
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2011-04 |
| Est. Completion | 2012-07 |
What the finished NCT01494077 record still lists
NCT01494077 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Laboratory processing for results is the first listed.
NCT01494077 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01494077 about?
NCT01494077 is a clinical study titled "Accuracy of Dilution of EUS-FNA Pancreatic Cyst Fluid for Carcinoembryonic Antigen (CEA) Measurement". The purpose of this research project is to determine if pancreatic cyst fluid can be diluted and provide an accurate Carcinoembryonic Antigen (CEA) level. The investigators hypothesis is that pancreatic cyst fluid obtained by EUS-FNA can be diluted effectively and accurately for the measurement of C...
What is the current status of trial NCT01494077?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2011-04. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01494077?
The interventions under investigation include: Laboratory processing for results (OTHER).
Who is sponsoring clinical trial NCT01494077?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia